The role of the pharmacy navigator in hematopoietic stem cell transplantation
DOI:
https://doi.org/10.46765/2675-374X.2025v6n1e279Keywords:
Patient Navigator, Hematopoietic Stem Cell Transplantation, Pharmaceutical ServicesAbstract
Hematopoietic stem cell transplantation (HSCT) is a complex procedure that requires rigorous pharmacotherapeutic management. This study aimed to describe the role of the pharmacy navigator in HSCT at the Hospital das Cl.nicas of the Medical School of the Universidade de S.o Paulo. For the assessment of pharmacist activities in HSCT, a literature review was conducted, alongside direct observation of pharmaceutical activities in different HSCT phases at the service: pre-transplant, hospitalization, discharge, and outpatient follow-up. It was observed that the pharmacy navigator plays a crucial role, including medication reconciliation, dose adjustments, monitoring drug interactions and toxicities, and providing health education to patients and the multidisciplinary team. Pharmacotherapeutic follow-up contributed to reducing medication errors, improving treatment adherence, and ensuring safer administration of immunosuppressants and antimicrobials. In conclusion, the presence of a pharmacy navigator in HSCT is essential to optimize treatment, prevent complications, and enhance patients’ quality of life, consolidating this professional as a key member of the multidisciplinary healthcare team.
References
1. Brazilian Society of Oncology Pharmacists. Hematopoietic stem cell transplantation: introduction for pharmacists. São Paulo: Segmento Farma; 2018.
2. Ice LL, Bartoo GT, McCullough KB, Wolf RC, Dierkhising RA, Mara KC, Jowsey-Gregoire SG, Damlaj M, Litzow MR, Merten JA. A prospective survey of outpatient medication adherence in adult allogeneic hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant. 2020;26(9):1627–34. https://doi.org/10.1016/j.bbmt.2020.05.020 DOI: https://doi.org/10.1016/j.bbmt.2020.05.020
3. Corrêa PM, Zuckermann J, Fischer GB, Castro MS. Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution. Pharm Pract. 2016;14(2):683. https://doi.org/10.18549/pharmpract.2016.02.683 DOI: https://doi.org/10.18549/PharmPract.2016.02.683
4. Ranaghan C, Boyle K, Meehan M, Moustapha S, Fraser P, Concert C. Effectiveness of a patient navigator on patient satisfaction in adult patients in an ambulatory care setting: a systematic review. JBI Database Syst Rev Implement Rep. 2016;14(8):172–218. https://doi.org/10.11124/jbisrir-2016-003049 DOI: https://doi.org/10.11124/JBISRIR-2016-003049
5. Neal CD, Weaver DT, Raphel TJ, Lietz AP, Flores EJ, Percac-Lima S, Knudsen AB, Pandharipande PV. Patient navigation to improve cancer screening in underserved populations: reported experiences, opportunities, and challenges. J Am Coll Radiol. 2018;15(11):1565–72. https://doi.org/10.1016/j.jacr.2018.03.001 DOI: https://doi.org/10.1016/j.jacr.2018.03.001
6. Fenton A, Downes N, Mendiola A, Cordova A, Lukity K, Imani J. Multidisciplinary management of breast cancer and role of the patient navigator. Obstet Gynecol Clin North Am. 2022;49(1):167–79. https://doi.org/10.1016/j.ogc.2021.11.011 DOI: https://doi.org/10.1016/j.ogc.2021.11.011
7. Conselho Federal de Farmácia. Resolução nº 727, de 30 de junho de 2022. Dispõe sobre a regulamentação da Telefarmácia. Diário Oficial da União. 2022;Seção 1:179.
8. Clemmons AB, Alexander M, DeGregory K, Kennedy L. The hematopoietic cell transplant pharmacist: roles, responsibilities, and recommendations from the ASBMT Pharmacy Special Interest Group. Biol Blood Marrow Transplant. 2018;24(5):914–22. https://doi.org/10.1016/j.bbmt.2017.12.803 DOI: https://doi.org/10.1016/j.bbmt.2017.12.803
9. Rice K. The oncology pharmacy navigator. Oncol Issues. 2019;34(3):34–42. https://doi.org/10.1080/10463356.2019.1596009 DOI: https://doi.org/10.1080/10463356.2019.1596009
10. Duncan N, Moreno-Martinez ME, Pires V, Domingos V, Bonnin A, Nezvalova-Henriksen K, Admiraal R, Bauters T, Langebrake C; Pharmacist Committee of the EBMT. Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey. Bone Marrow Transplant. 2023;58(7):829–31. https://doi.org/10.1038/s41409-023-01983-9 DOI: https://doi.org/10.1038/s41409-023-01983-9
11. Brazilian Society of Oncology Pharmacists. Hematopoietic stem cell transplantation: introduction for pharmacists. São Paulo: Segmento Farma; 2021. v. 2.
12. Christiani T, Rocha G, Nogueira T. Documentary structuring of clinical pharmacy service in an intensive care unit of a large public hospital. Rev Saúde Coletiva. 2021;11(63):5520–35. https://doi.org/10.36489/saudecoletiva.2021v11i63p5520-5535 DOI: https://doi.org/10.36489/saudecoletiva.2021v11i63p5520-5535
13. Farias TF, Aguiar KS, Rotta I, Belletti KMS, Carlotto J. Implementing a clinical pharmacy service in hematology. Einstein. 2016;14(3):384–90. https://doi.org/10.1590/S1679-45082016AO3667 DOI: https://doi.org/10.1590/S1679-45082016AO3667
14. Ruder AD, Smith DL, Madsen MT, Kass FH 3rd. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011;17(4):425–32. https://doi.org/10.1177/1078155210389216 DOI: https://doi.org/10.1177/1078155210389216
15. Chieng R, Coutsouvelis J, Poole S, Dooley MJ, Booth D. Implementation of a clinical pharmacy service to an allogeneic stem cell transplant ambulatory clinic. J Pharm Pract Res. 2014;44(3):105–7. https://doi.org/10.1002/jppr.1012 DOI: https://doi.org/10.1002/jppr.1012
16. Bauters TGM, Vinent Genestar JLL, Delaney J, Mycroft J, Vandenbroucke J. Role of the clinical pharmacist in a paediatric haemato-oncology stem cell transplantation ward. Eur J Hosp Pharm. 2014;21(5):309–12. DOI: https://doi.org/10.1136/ejhpharm-2013-000397
17. Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole D, Hari P. Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2011;17(12):1765–74. https://doi.org/10.1016/j.bbmt.2011.05.005 DOI: https://doi.org/10.1016/j.bbmt.2011.05.005
18. Hyeda A, da Costa ESM. A preliminary analysis of chemotherapy waste in cancer treatment. Value Health Reg Issues. 2015;8:107–11. DOI: https://doi.org/10.1016/j.vhri.2015.08.001
19. Ibrahim N. Impact of dose rounding of cancer therapy on cost avoidance: a pilot study. Health Econ Ther Pathways. 2013;4(14):169–72. https://doi.org/10.7175/fe.v14i4.658 DOI: https://doi.org/10.7175/fe.v14i4.658
20. Taylor TL, Dupuis LL, Nicksy D, Girvan C. Clinical pharmacy services in a pediatric hematology/oncology clinic: A description and assessment. Can J Hosp Pharm. 2023;52(1):56–62. https://doi.org/10.4212/cjhp.v52i1.1763
21. Zheng L, Pon T, Bajorek S, Le K, Hluhanich R, Ren Y, et al. Impact of pharmacist-led discharge medication reconciliation on error and patient harm prevention at a large academic medical center. J Am Coll Clin Pharm. 2024;7(8):787–94. https://doi.org/10.1002/jac5.1980 DOI: https://doi.org/10.1002/jac5.1980
22. Marques LF, Romano-Lieber NS. Strategies for patient safety in the medication use process after hospital discharge. Physis. 2014;24(2):401–20. https://doi.org/10.1590/S0103-73312014000200005 DOI: https://doi.org/10.1590/S0103-73312014000200005
23. Lima LF, Martins BCC, Oliveira FRP, Cavalcante RMA, Magalhães VP, Firmino PYM, Adriano LS, Silva AM, Flor MJN, Néri EDR. Pharmaceutical orientation at hospital discharge of transplanted patients: strategy for patient safety. Einstein. 2016;14(3):359–65. https://doi.org/10.1590/S1679-45082016AO3481 DOI: https://doi.org/10.1590/S1679-45082016AO3481
24. Alexander MD, Rao KV, Khan TS, Deal AM. ReCAP: Pharmacists’ impact in hematopoietic stem-cell transplantation: economic and humanistic outcomes. J Oncol Pract. 2016;12(2):147–8, e18–26. https://doi.org/10.1200/jop.2015.008797 DOI: https://doi.org/10.1200/JOP.2015.008797
25. Conselho Federal de Farmácia. Resolução nº 292, de 24 de maio de 1996. Ratifica competência legal para o exercício da atividade de nutrição parenteral e enteral pelo farmacêutico. Diário Oficial da União. 1996; Seção 1:11123.
26. Whitman A, Fitch E, Nightingale G. The role of oncology pharmacists and comprehensive medication reconciliation in informing treatment plans for older adults with cancer and downstream outcomes. Curr Opin Support Palliat Care. 2023;17(1):3–7. https://doi.org/10.1097/spc.0000000000000634 DOI: https://doi.org/10.1097/SPC.0000000000000634
27. Barboza-Zanetti MO, Barboza-Zanetti AC, Rodrigues-Abjaude SA, Pinto-Simões B, Leira-Pereira LR. Clinical pharmacists’ contributions to hematopoietic stem cell transplantation: A systematic review J Oncol Pharm Pract. 2018;25(2):423–33. https://doi.org/10.1177/1078155218782372 DOI: https://doi.org/10.1177/1078155218782372
28. Santos BL, Lima-D’Oliveira LC, Magedanz L, Galato D. Profile of clinical pharmacy services in hematopoietic stem cell transplantation centers in Brazil. Rev Bras Farm Hosp Serv Saude. 2022;13(1):0744. https://doi.org/10.30968/rbfhss.2022.131.0744 DOI: https://doi.org/10.30968/rbfhss.2022.131.0744
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Giovanna Fernandes Lago, Carolina Ferreira dos Santos, Andressa Pinheiro Diniz, Leonardo Jun Otuyama, Andrea Cassia Pereira Sforsin, Vanusa Barbosa Pinto
This work is licensed under a Creative Commons Attribution 4.0 International License.
